BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15831457)

  • 1. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
    Ihara M; Yamamoto H; Kikuchi A
    Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
    Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
    Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
    Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
    Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumoylation is involved in beta-catenin-dependent activation of Tcf-4.
    Yamamoto H; Ihara M; Matsuura Y; Kikuchi A
    EMBO J; 2003 May; 22(9):2047-59. PubMed ID: 12727872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies.
    Sachdev S; Bruhn L; Sieber H; Pichler A; Melchior F; Grosschedl R
    Genes Dev; 2001 Dec; 15(23):3088-103. PubMed ID: 11731474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
    Lee PS; Chang C; Liu D; Derynck R
    J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
    Gross M; Yang R; Top I; Gasper C; Shuai K
    Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
    Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
    Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein.
    Sun Y; Perera J; Rubin BP; Huang J
    J Biol Chem; 2011 May; 286(21):18623-32. PubMed ID: 21454665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy.
    Chun TH; Itoh H; Subramanian L; Iñiguez-Lluhí JA; Nakao K
    Circ Res; 2003 Jun; 92(11):1201-8. PubMed ID: 12750312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity.
    Martin N; Schwamborn K; Urlaub H; Gan B; Guan JL; Dejean A
    Mol Cell Biol; 2008 Apr; 28(8):2771-81. PubMed ID: 18285457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
    Deng Z; Wan M; Sui G
    Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
    Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
    J Virol; 2017 May; 91(10):. PubMed ID: 28250117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock.
    Martin N; Schwamborn K; Schreiber V; Werner A; Guillier C; Zhang XD; Bischof O; Seeler JS; Dejean A
    EMBO J; 2009 Nov; 28(22):3534-48. PubMed ID: 19779455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.
    Bischof O; Schwamborn K; Martin N; Werner A; Sustmann C; Grosschedl R; Dejean A
    Mol Cell; 2006 Jun; 22(6):783-794. PubMed ID: 16793547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.
    Conn KL; Wasson P; McFarlane S; Tong L; Brown JR; Grant KG; Domingues P; Boutell C
    J Virol; 2016 May; 90(9):4807-4826. PubMed ID: 26937035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of E1AF transcriptional activity by sumoylation and PIASy.
    Nishida T; Terashima M; Fukami K; Yamada Y
    Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
    Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
    J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.